Maximizing laser therapy success for Port-Wine Birthmarks in kids
Official title: Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Run by University of Texas Southwestern Medical Center · NCT07183644 · Data updated 2026-11-12
This study tests different laser treatment sequences to see which approach clears Port-Wine Stains in children with fewer sessions and less need for anesthesia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Months to 18 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 2 sites (Dallas, Texas and 1 other locations) |
| Status | Recruiting |
| Started | July 2026 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT07183644 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Candidates are children and adolescents aged 2 months to 18 years with a stable Port-Wine Stain who have no contraindications to laser therapy and whose guardians can provide consent.
✕Probably not a fit
Patients with active skin infections, recent laser therapy, photosensitizing medication use, anesthesia intolerance, or significant allergies to anesthesia may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares five laser treatment modalities for Port-Wine Birthmarks in pediatric participants, using up to two sessions and selecting the most effective modality for follow-up until clearance or a plateau is reached. If no further improvement is seen, a second round with all modalities helps identify differences in efficacy between treatments and between primary and refractory cases. Outcomes will be analyzed to determine which modality or sequence provides the best results and whether refractory cases benefit differently. The study is interventional and seeks to optimize treatment efficiency and safety in the pediatric population.
Why it matters
Potential benefit: If successful, patients may achieve clearance with fewer treatment sessions and reduced anesthesia exposure.
How similar studies have gone: Previous studies have explored multiple laser modalities for Port-Wine Stains, but this trial aims to directly compare sequences and combinations to optimize outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Port Wine Stain. * Age Range: 2mo to 18 years of age. * Stable PWS: The port wine stain should be stable, meaning there is no active inflammation or infection present, and it should not be changing in size or color due to factors like injury or disease. * signed Consent: For ethical reasons, participants must be able to provide informed consent. In the case of minors, consent would generally be required from a parent or legal guardian. General Health: Participants should generally be in good health, with no contraindications for laser therapy, such as certain skin conditions, infections, or hypersensitivity to light. Exclusion Criteria: * severe allergies to anesthesia * active skin infections or inflammation * recent laser therapy * use of Photosensitizing medications * participation in other laser studies
Where it's running
-
Children's Medical Center
Dallas, Texas, United States Recruiting -
Children's Medical Center
Plano, Texas, United States Recruiting
Study contacts
- Principal investigator: James Seaward, MD — University of Texas Southwestern Medical Center
- Study coordinator: James R Seaward, MD
- Email: james.seaward@utsouthwestern.edu
- Phone: 214 456 5250
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing pulsed dye, KTP, and sequential KTP→PDL laser treatment for port‑wine stains
This study will try pulsed dye laser, KTP laser, and a sequential KTP then PDL approach on different parts of your port‑wine stain to see which lightens the lesion best and is most tolerable.
-
ADVATx laser treatment for port-wine stains (vascular birthmarks)
This project will test whether four monthly ADVATx laser treatments can lighten port-wine stains in people with lesions at least 15 cm² and Fitzpatrick skin types I–IV.
-
Treatment of port wine birthmarks with a laser
This study is testing a laser treatment for port wine birthmarks to see which method works better and is easier for patients to handle.
-
Evaluating Light Dose for Treating Port-Wine Birthmarks with Hemoporfin PDT
This study is testing how well a new light treatment using Hemoporfin can help people with port-wine birthmarks on their face and neck.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.